Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose.
25 ug of the indicated Human whole cell extracts was loaded onto a 6-18% SDS-PAGE gel. 1 ug/mL of the antibody was used in this experiment. Isoforms containing the peptide sequence are present at ~77 and ~64 kDa.
WB Suggested Anti-TRAK1 Antibody Titration: 0.2-1 ug/ml ELISA Titer: 1:1562500 Positive Control: HT1080 cell lysateThere is BioGPS gene expression data showing that TRAK1 is expressed in HT1080
Host: Rabbit Target Name: TRAK1 Sample Type: HepG2 Antibody Dilution: 1.0ug/mlTRAK1 is strongly supported by BioGPS gene expression data to be expressed in Human HepG2 cells
Host: Rabbit Target Name: TRAK1 Sample Type: Hela Antibody Dilution: 1.0ug/mlTRAK1 is supported by BioGPS gene expression data to be expressed in HeLa
Host: Rabbit Target Name: TRAK1 Sample Type: HT1080 Antibody Dilution: 1.0ug/mlThere is BioGPS gene expression data showing that TRAK1 is expressed in HT1080
Host: Rabbit Target Name: TRAK1 Sample Type: HCT15 Antibody Dilution: 1.0ug/mlThere is BioGPS gene expression data showing that TRAK1 is expressed in HCT15
Host: Rabbit Target: TRAK1 Positive control (+): HepG2 Cell Lysate (HG) Negative control (-): Human Liver Tumor (T-LI) Antibody concentration: 1ug/ml
TRAK1 antibody - middle region (ARP54521_P050) in Human HT1080 using Western Blot
* VAT and and shipping costs not included. Errors and price changes excepted